Jan. 14 at 2:23 AM
$IBRX I feel like I am beating this to death but obviously there is a deal. And obviously the $ part has been figured out regarding who pays to who. So this somehow changed to a US/Saudi thing. How can this not be seen as the US not also putting in money? And the Saudi's are moving forward with this regardless of what the US FDA is doing. So how do you call it a US Saudi deal if IBRX is going full blast in the SA while they are struggling under FDA restrictions in their own country? Another thing.
Does anyone think that the Saudi's are not licking their chops over Lymphopenia and the anti-ageing concept? It is the 2000lb gorilla in the room. FDA is going to have to let that go too, if they want it to be a US/Saudi
deal.
